Join us for a discussion between Dr Patrick Murphy, principal investigator of the HOT-HMV study and Dr Eline Gantzhorn from Vejle Hospital, Denmark about the health economic aspect of home NIV in COPD.
Home NIV has benefits for COPD patients with persistent hypercapnia.¹² The therapy can reduce mortality,¹ the risk of hospital admissions² and improve quality of life¹ in these patients.
That said, can improved clinical outcomes be achieved whilst optimizing cost of care?
1 Köhnlein et al, Lancet Respir Med. 2014;2(9):698-705.
2 Murphy et al. JAMA. 2017 Jun 6;317(21):2177-2186